Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Orzaks Ilac Ve Kimyanayi Ticaret AS's accounts receivables for the quarter that ended in Dec. 2025 was ₺2,455 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Orzaks Ilac Ve Kimyanayi Ticaret AS's Days Sales Outstanding for the quarter that ended in Dec. 2025 was 61.12.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Orzaks Ilac Ve Kimyanayi Ticaret AS's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was ₺-6.90.
Orzaks Ilac Ve Kimyanayi Ticaret AS Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Orzaks Ilac Ve Kimyanayi Ticaret AS's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Orzaks Ilac Ve Kimyanayi Ticaret AS's accounts receivable are only considered to be worth 75% of book value:
Orzaks Ilac Ve Kimyanayi Ticaret AS's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Orzaks Ilac Ve Kimyanayi Ticaret AS Accounts Receivable Related Terms
Orzaks Ilac Ve Kimyanayi Ticaret AS Accounts Receivable Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orzaks Ilac Ve Kimyanayi Ticaret AS Accounts Receivable Chart
Orzaks Ilac Ve Kimyanayi Ticaret AS Annual Data
Trend
Dec23
Dec24
Dec25
Accounts Receivable
2,404.42
1,504.94
2,455.39
Orzaks Ilac Ve Kimyanayi Ticaret AS Semi-Annual Data
What does a Accounts Receivable of ₺2,455 Mil mean?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a Accounts Receivable of ₺2,455 Mil as of Dec. 2025. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS's Accounts Receivable too high?
Orzaks Ilac Ve Kimyanayi Ticaret AS's current Accounts Receivable is ₺2,455 Mil. Overall, Orzaks Ilac Ve Kimyanayi Ticaret AS has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Orzaks Ilac Ve Kimyanayi Ticaret AS's Accounts Receivable compare to KHC and GIS?
Orzaks Ilac Ve Kimyanayi Ticaret AS's Accounts Receivable of ₺2,455 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Consumer Packaged Goods company?
A good Accounts Receivable depends on the Consumer Packaged Goods industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors. Orzaks Ilac Ve Kimyanayi Ticaret AS's current Accounts Receivable is ₺2,455 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS stock overvalued right now?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a current Accounts Receivable of ₺2,455 Mil. The current Accounts Receivable is ₺2,455 Mil. Orzaks Ilac Ve Kimyanayi Ticaret AS's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX), the current Accounts Receivable is ₺2,455 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Orzaks Ilac Ve Kimya Sanayi Ticaret AS operates as a sports nutrition brand. Its products are Vitamin Series, Vitamin D Series, Mineral Series, Magnesium Series, Omega 3 Series, Plant Extracts, Immune Series, Probiotic Series, Bone And Joint Series, and Others. The group offers its products under various brands such as Ocean, Day2Day, Imunol, Cosakondrin, Efervit, Bigflor, and Strains.
18GF Score
Get the complete analysis for IST:ORZAX
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:ORZAX has been successfully added to your 
